Nkarta, a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune disease, announced the appointment of Shawn Rose, M.D. Ph.D.,...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Aitia, the leader in computationally discovering and applying new knowledge of biological causes of disease to pharmaceutical discovery and development, announced a collaboration with...
Biodextris, a leading Contract Development and Manufacturing Organization (CDMO) rooted in the legacy of GSK's biologics and vaccine operations and backed by the healthcare-focused...
Nutcracker Therapeutics, a contract, research, development and manufacturing organization (CRDMO), announced the NMU-Symphony™ system, the second generation of its Nutcracker Manufacturing Unit (NMU). This...
